Most read article(s)

Open Access
Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile
Tjeerd Barf, Todd Covey, Raquel Izumi, Bas van de Kar, Michael Gulrajani, Bart van Lith, Maaike van Hoek, Edwin de Zwart, Diana Mittag, Dennis Demont, Saskia Verkaik, Fanny Krantz, Paul G. Pearson, Roger Ulrich and Allard Kaptein

Journal of Pharmacology and Experimental Therapeutics November 2017, 363 (2) 240-252; DOI: https://doi.org/10.1124/jpet.117.242909
You have access
Pine Bark Extracts: Nutraceutical, Pharmacological, and Toxicological Evaluation
Ying-Ya Li, Jiao Feng, Xiao-Lu Zhang and Ying-Yu Cui

Journal of Pharmacology and Experimental Therapeutics April 2015, 353 (1) 9-16; DOI: https://doi.org/10.1124/jpet.114.220277
You have access
Targeting the Myofibroblast Genetic Switch: Inhibitors of Myocardin-Related Transcription Factor/Serum Response Factor–Regulated Gene Transcription Prevent Fibrosis in a Murine Model of Skin Injury
Andrew J. Haak, Pei-Suen Tsou, Mohammad A. Amin, Jeffrey H. Ruth, Phillip Campbell, David A. Fox, Dinesh Khanna, Scott D. Larsen and Richard R. Neubig

Journal of Pharmacology and Experimental Therapeutics June 2014, 349 (3) 480-486; DOI: https://doi.org/10.1124/jpet.114.213520
Open Access
ELX-02 Generates Protein via Premature Stop Codon Read-Through without Inducing Native Stop Codon Read-Through Proteins
Daniel K. Crawford, Iris Alroy, Neal Sharpe, Matthew M. Goddeeris and Greg Williams

Journal of Pharmacology and Experimental Therapeutics August 2020, 374 (2) 264-272; DOI: https://doi.org/10.1124/jpet.120.265595
You have access
Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation
Keagan P. Collins, Kristen M. Jackson and Daniel L. Gustafson

Journal of Pharmacology and Experimental Therapeutics June 2018, 365 (3) 447-459; DOI: https://doi.org/10.1124/jpet.117.245639
You have access
Artificial Oxygen Carriers—Past, Present, and Future—a Review of the Most Innovative and Clinically Relevant Concepts
Katja B. Ferenz and Andrea U. Steinbicker

Journal of Pharmacology and Experimental Therapeutics May 2019, 369 (2) 300-310; DOI: https://doi.org/10.1124/jpet.118.254664
You have access
Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model
Shun Xin Wang-Lin, Ruth Olson, Janet M. Beanan, Ulrike MacDonald, Thomas A. Russo and Joseph P. Balthasar

Journal of Pharmacology and Experimental Therapeutics March 2019, 368 (3) 475-489; DOI: https://doi.org/10.1124/jpet.118.253617
You have access
Renal Effects of Dapagliflozin in People with and without Diabetes with Moderate or Severe Renal Dysfunction: Prospective Modeling of an Ongoing Clinical Trial
K. Melissa Hallow, David W. Boulton, Robert C. Penland, Gabriel Helmlinger, Emily H. Nieves, Daniël H. van Raalte, Hiddo L. Heerspink and Peter J. Greasley

Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 76-91; DOI: https://doi.org/10.1124/jpet.120.000040
You have access
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino, Roberta Verde, Massimo Vaia, Marco Allarà, Teresa Iuvone and Vincenzo Di Marzo

Journal of Pharmacology and Experimental Therapeutics June 2018, 365 (3) 652-663; DOI: https://doi.org/10.1124/jpet.117.244368
You have access
Regulation of the β-Adrenergic Receptor Signaling Pathway in Sustained Ligand-Activated Preconditioning
L. E. See Hoe, S. R. Foster, L. Wendt, H. H. Patel, J. P. Headrick and J. N. Peart

Journal of Pharmacology and Experimental Therapeutics April 2019, 369 (1) 37-46; DOI: https://doi.org/10.1124/jpet.118.251660

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals